Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2001. Upgrade now.
Date Value
December 31, 2023 51.53B
September 30, 2023 51.03B
June 30, 2023 51.13B
March 31, 2023 52.74B
December 31, 2022 53.72B
September 30, 2022 54.16B
June 30, 2022 54.33B
March 31, 2022 53.76B
December 31, 2021 52.18B
September 30, 2021 51.39B
June 30, 2021 49.80B
March 31, 2021 47.79B
December 31, 2020 47.11B
September 30, 2020 47.10B
June 30, 2020 48.08B
March 31, 2020 49.04B
December 31, 2019 48.79B
September 30, 2019 48.70B
June 30, 2019 48.54B
March 31, 2019 47.82B
December 31, 2018 45.13B
September 30, 2018 43.44B
June 30, 2018 42.10B
March 31, 2018 40.37B
December 31, 2017 39.46B
Date Value
September 30, 2017 38.85B
June 30, 2017 38.63B
March 31, 2017 42.42B
December 31, 2016 45.18B
September 30, 2016 48.01B
June 30, 2016 51.02B
March 31, 2016 50.92B
December 31, 2015 51.24B
September 30, 2015 52.37B
June 30, 2015 53.35B
March 31, 2015 54.12B
December 31, 2014 55.18B
September 30, 2014 55.16B
June 30, 2014 54.73B
March 31, 2014 54.23B
December 31, 2013 53.33B
September 30, 2013 52.66B
June 30, 2013 51.95B
March 31, 2013 51.47B
December 31, 2012 51.10B
September 30, 2012 50.70B
June 30, 2012 50.87B
March 31, 2012 51.15B
December 31, 2011 50.85B
September 30, 2011 50.70B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

47.10B
Minimum
Sep 2020
54.33B
Maximum
Jun 2022
50.57B
Average
51.03B
Median
Sep 2023

Revenue (TTM) Benchmarks

Affimed NV 8.941M
InflaRx NV --
MorphoSys AG 257.99M
BioNTech SE 4.122B
Immatics NV 58.49M